The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression
Open accessAbstract
Mesenchymal stromal cells (MSCs) exert broad immunosuppressive potential, modulating the activity of cells of innate and adaptive immune systems. As MSCs become accepted as a therapeutic option for the treatment of immunological disorders such as Graft versus Host Disease, our need to understand the intricate details by which they exert their effects is crucial. Programmed death-1 (PD-1) is an important regulator in T cell activation and homeostatic control. It has been reported that this pathway may be important in contact-dependent mediated immunomodulation by MSCs. The aim of this study was to establish whether MSCs, in addition to their cell-surface expression, are able to secrete PD-1 ligands (PD-L1 and PD-L2) and their potential importance in modulating contact-independent mechanisms of MSC immunosuppression. Here we report that MSCs express and secrete PD-L1 and PD-L2 and that this is regulated by exposure to interferon γ and tumor necrosis factor α. MSCs, via their secretion of PD-1 ligands, suppress the activation of CD4+ T cells, downregulate interleukin-2 secretion and induce irreversible hyporesponsiveness and cell death. Suppressed T cells demonstrated a reduction in AKT phosphorylation at T308 and a subsequent increase in FOXO3 expression that could be reversed with blockade of PD-L1. In conclusion, we demonstrate for the first time, that MSCs are able to secrete PD-1 ligands, with this being the first known report of a biological role for PD-L2 in MSCs. These soluble factors play an important role in modulating immunosuppressive effects of MSCs directly on T cell behavior and induction of peripheral tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, H. H., Min, X., Wang, Q., Leung, F. W., Liu, S., Yu, Z., Yu, T., Wang, C., An, G., Sha, W., et al. (2015) · Scientific Reports · doi:10.1038/srep08718 · Cited by 113
RetractedAkt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Self-citationPD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S. E., & Ringdén, O. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01176.x · Cited by 1,368
Self-citationBone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W.-F., & Dazzi, F. (2005) · Blood · doi:10.1182/blood-2004-09-3696 · Cited by 1,150
Expression of Programmed Death 1 Ligands by Murine T Cells and APC
Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5538 · Cited by 951
Augello, A., Tasso, R., Negrini, S. M., Amateis, A., Indiveri, F., Cancedda, R., & Pennesi, G. (2005) · European Journal of Immunology · doi:10.1002/eji.200425405 · Cited by 696
Rasmusson, I., Ringdén, O., Sundberg, B., & Le Blanc, K. (2003) · Transplantation · doi:10.1097/01.tp.0000082540.43730.80 · Cited by 663
Self-citationLiu, Y., Wang, L., Kikuiri, T., Akiyama, K., Chen, C., Xu, X., Yang, R., Chen, W., Wang, S., & Shi, S. (2011) · Nature Medicine · doi:10.1038/nm.2542 · Cited by 655
Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J. I., Akiba, H., Tushima, F., Azuma, M., Yagita, H., Sayegh, M. H., & Khoury, S. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022119 · Cited by 506
Nishimura, H. (1998) · International Immunology · doi:10.1093/intimm/10.10.1563 · Cited by 500
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells
Le Blanc, K., Samuelsson, H., Gustafsson, B., Remberger, M., Sundberg, B., Arvidson, J., Ljungman, P., Lönnies, H., Nava, S., & Ringdén, O. (2007) · Leukemia · doi:10.1038/sj.leu.2404777 · Cited by 443
Self-citationRegulation of NF-κB, Th Activation, and Autoinflammation by the Forkhead Transcription Factor Foxo3a
Lin, L., Hron, J. D., & Peng, S. L. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.016 · Cited by 421
IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells
English, K., Barry, F. P., Field-Corbett, C. P., & Mahon, B. P. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.04.001 · Cited by 415
Melief, S. M., Schrama, E., Brugman, M. H., Tiemessen, M. M., Hoogduijn, M. J., Fibbe, W. E., & Roelofs, H. (2013) · Stem Cells · doi:10.1002/stem.1432 · Cited by 406
Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling
Pagès, F., Ragueneau, M., Rottapel, R., Truneh, A., Nunes, J., Imbert, J., & Olive, D. (1994) · Nature · doi:10.1038/369327a0 · Cited by 398
Sheng, H., Wang, Y., Jin, Y., Zhang, Q., Zhang, Y., Wang, L., Shen, B., Yin, S., Liu, W., Cui, L., et al. (2008) · Cell Research · doi:10.1038/cr.2008.80 · Cited by 388
Metz, R., Rust, S., DuHadaway, J. B., Mautino, M. R., Munn, D. H., Vahanian, N. N., Link, C. J., & Prendergast, G. C. (2012) · OncoImmunology · doi:10.4161/onci.21716 · Cited by 384
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Moll, G., Rasmusson-Duprez, I., von Bahr, L., Connolly-Andersen, A.-M., Elgue, G., Funke, L., Hamad, O. A., Lönnies, H., Magnusson, P. U., Sanchez, J., et al. (2012) · Stem Cells · doi:10.1002/stem.1111 · Cited by 357
Self-citationMokarizadeh, A., Delirezh, N., Morshedi, A., Mosayebi, G., Farshid, A.-A., & Mardani, K. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.06.001 · Cited by 320
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
Carlsson, P.-O., Schwarcz, E., Korsgren, O., & Le Blanc, K. (2015) · Diabetes · doi:10.2337/db14-0656 · Cited by 315
Self-citationInterferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell
Stagg, J., Pommey, S., Eliopoulos, N., & Galipeau, J. (2006) · Blood · doi:10.1182/blood-2005-07-2793 · Cited by 290
Bennett, F., Luxenberg, D., Ling, V., Wang, I.-M., Marquette, K., Lowe, D., Khan, N., Veldman, G., Jacobs, K. A., Valge-Archer, V. E., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.711 · Cited by 281
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Gianchecchi, E., Delfino, D. V., & Fierabracci, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.003 · Cited by 270
Chinnadurai, R., Copland, I. B., Patel, S. R., & Galipeau, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301828 · Cited by 266
Perruche, S., Zhang, P., Liu, Y., Saas, P., Bluestone, J. A., & Chen, W. (2008) · Nature Medicine · doi:10.1038/nm1749 · Cited by 240
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
Chikuma, S., Terawaki, S., Hayashi, T., Nabeshima, R., Yoshida, T., Shibayama, S., Okazaki, T., & Honjo, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900080 · Cited by 231
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
Ghiotto, M., Gauthier, L., Serriari, N., Pastor, S., Truneh, A., Nunes, J. A., & Olive, D. (2010) · International Immunology · doi:10.1093/intimm/dxq049 · Cited by 229
Mougiakakos, D., Jitschin, R., Johansson, C. C., Okita, R., Kiessling, R., & Le Blanc, K. (2011) · Blood · doi:10.1182/blood-2010-12-324038 · Cited by 205
Self-citationImmunomodulatory effects of human foetal liver-derived mesenchymal stem cells
Götherström, C., Ringdén, O., Westgren, M., Tammik, C., & Le Blanc, K. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704111 · Cited by 202
Self-citationAppleman, L. J., van Puijenbroek, A. A. F. L., Shu, K. M., Nadler, L. M., & Boussiotis, V. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2729 · Cited by 201
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway
Luz-Crawford, P., Noël, D., Fernandez, X., Khoury, M., Figueroa, F., Carrión, F., Jorgensen, C., & Djouad, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045272 · Cited by 195
Patsoukis, N., Li, L., Sari, D., Petkova, V., & Boussiotis, V. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00319-13 · Cited by 187
Oh, K.-W., Moon, C., Kim, H. Y., Oh, S.-I., Park, J., Lee, J. H., Chang, I. Y., Kim, K. S., & Kim, S. H. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0212 · Cited by 180
Melief, S. M., Geutskens, S. B., Fibbe, W. E., & Roelofs, H. (2013) · Haematologica · doi:10.3324/haematol.2012.078055 · Cited by 171
In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses
Shin, T., Yoshimura, K., Shin, T., Crafton, E. B., Tsuchiya, H., Housseau, F., Koseki, H., Schulick, R. D., Chen, L., & Pardoll, D. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050072 · Cited by 159
Kronsteiner, B., Wolbank, S., Peterbauer, A., Hackl, C., Redl, H., van Griensven, M., & Gabriel, C. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0031 · Cited by 158
Velu, V., Kannanganat, S., Ibegbu, C., Chennareddi, L. S., Villinger, F. J., Freeman, G. J., Ahmed, R., & Amara, R. R. (2007) · Journal of Virology · doi:10.1128/jvi.00024-07 · Cited by 134
Dezutter‐Dambuyant, C., Durand, I., Alberti, L., Bendriss‐Vermare, N., Valladeau‐Guilemond, J., Duc, A., Magron, A., Morel, A., Sisirak, V., Rodriguez, C., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1091146 · Cited by 100
Fujiwara, H., Maeda, Y., Kobayashi, K., Nishimori, H., Matsuoka, K., Fujii, N., Kondo, E., Tanaka, T., Chen, L., Azuma, M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400954 · Cited by 80
Kwon, M., Noh, M., Oh, K., Cho, K., Kang, B., Kim, K., Kim, Y., & Kim, S. H. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12814 · Cited by 72
Khairoun, M., & Korevaar, S. S. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s6-001 · Cited by 63
CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1–Dependent Regulation of Type 1 Diabetes
Kadri, N., Korpos, É., Gupta, S., Briet, C., Löfbom, L., Yagita∥, H., Lehuen, A., Boîtard, C., Holmberg, D., Sorokin, L. M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101390 · Cited by 58
Self-citationCloning and Identification of Two Novel Splice Variants of Human PD-L2
He, X., Liu, Y., Xu, L., & Zeng, Y.-Y. (2004) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/36.4.284 · Cited by 41
Zafranskaya, M. M., Nizheharodava, D. B., Yurkevich, M., Иванчик, Г. И., Demidchik, Y. E., Kozhukh, H., & As, F. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12102 · Cited by 30
Bishop, K. D., Harris, J. E., Mordes, J. P., Greiner, D. L., Rossini, A. A., Czech, M., & Phillips, N. E. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.01.008 · Cited by 30
Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes
Won, T., Jung, Y. J., Kwon, S. J., Lee, Y. J., Lee, D. I., Min, H., Park, E. S., Joo, S. S., & Hwang, K. W. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1115-3 · Cited by 24
Cited by
Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential
Song, N., Scholtemeijer, M., & Shah, K. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.06.009 · Cited by 948
Monteran, L., & Erez, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01835 · Cited by 675
Weiss, A. R. R., & Dahlke, M. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01191 · Cited by 695
Immune modulation by mesenchymal stem cells
Jiang, W., & Xu, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12712 · Cited by 650
Biological functions of mesenchymal stem cells and clinical implications
Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas-Freiss, N., & Suganuma, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03125-1 · Cited by 624
Metadata
- Authors
- Davies, L. C., Heldring, N., Kadri, N., & Le Blanc, K.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-26
- Volume
- 35
- Issue
- 3
- Pages
- 766-776
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2526446404
- Cited by
- 349
- References
- 49
- FWCI
- 13.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.